New Jersey's S 2260 strengthens legal protections for patients and providers accessing or delivering reproductive and gender-affirming health care services within the state. The bill explicitly defines "legally protected health care activities" to include seeking, providing, or assisting with these services (such as abortion, contraception, or gender-affirming care), regardless of a patient's location. It prohibits obstruction, intimidation, or physical barriers at facilities offering these services and grants licensing boards authority to impose civil penalties for violations. This directly affects patients traveling to New Jersey for care (not available in their home states) and healthcare providers operating in these fields. The law codifies existing protections to prevent harassment or violence against these services, following increased threats and protests nationwide after the overturning of Roe v. Wade.
This bill establishes a Social Media Research Center at a New Jersey four-year public university selected by the Higher Education Secretary. The center will conduct research on social media's effects on youth mental health, develop online safety resources for public schools, and provide recommendations to state agencies. It will also administer grants for social media research using a peer-reviewed process modeled after the NIH, and require annual reports on its work. The bill directly affects New Jersey public universities (as hosts), public schools (through educational resources), and state agencies (by requiring data sharing).
This New Jersey bill establishes the "Privacy Protection Act" to limit how government agencies and healthcare facilities collect and share certain personal information. It prohibits them from requesting details like immigration status, citizenship, social security numbers, or tax IDs unless necessary for specific public services, benefits, or healthcare delivery (with healthcare exceptions for patient safety). The bill requires written consent in the person's preferred language for sharing any collected data, detailing exactly what will be shared, why, and confirming consent is voluntary without retaliation. It also bans selling or sharing vehicle license plate data except under court orders, subpoenas, or with explicit written consent, and mandates government entities to update privacy policies within one year.
S 712 requires New Jersey's Department of State to create a public "Reproductive Health Travel Advisory" to help residents traveling while pregnant make informed decisions. The advisory will categorize all U.S. states using a color-coded system: "Blue" (full access without legal risk), "Yellow" (restricted access with potential legal consequences), and "Red" (extreme restrictions risking denial of emergency care). It will detail each state's laws on abortion bans, waiting periods, insurance coverage, and legal protections for patients and providers. The advisory must be posted on the state website and updated whenever another state changes its reproductive healthcare laws. This directly affects New Jersey residents who may need to travel during pregnancy for medical emergencies.
This bill adds 7-hydroxymitragynine (7-OH), a psychoactive compound found in Kratom, to New Jersey's Schedule I list of controlled substances. It directly affects anyone possessing, manufacturing, distributing, or using 7-OH in the state. Under the law, 7-OH would be classified as a substance with "high potential for abuse" and "no accepted medical use," making it illegal for non-medical purposes. Possession of 1 ounce or more would be a second-degree crime, while smaller amounts would be a third-degree crime under New Jersey's drug laws.
